Total Funding
45
Total FundingSeries C raised
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
141725
GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.
Ming Yang: SVP, Research & Development- Julie Eastland: Board Member / Audit Committee ChairPast Role: Rainier Therapeutics, Chief financial & business officer
About the Company
GrayBug is a pharmaceutical company that develops transformative medicines for ocular diseases. They also develop therapies for inflammatory diseases with unmet needs. Their proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury.
Women Founded
